Nav: Home

New gene therapy prevents muscle wasting associated with cancer

July 22, 2016

Australian researchers have demonstrated a new gene therapy-based strategy that could be used to prevent the loss of muscle mass and physical strength associated with advanced cancer. The findings are published today in the journal Science Translational Medicine.

Up to 80 per cent of patients with advanced cancer suffer from "cachexia", a condition of pronounced weight loss, frailty and fatigue, associated with severe wasting of muscle and fat. For these individuals, muscle wasting is a predictor of poor outcomes and reduced survival, as debilitating frailty leads to loss of independent movement, impaired respiratory function, and reduced tolerance for aggressive chemotherapy regimens.

To-date, Cachexia has been difficult to treat. Most efforts have focused on trying to "block" proteins released from the tumour or immune system which are responsible for causing cachexia by targeting proteins in the blood stream. However, some of the most promising experimental therapies have been abandoned after clinical trials raised concerns over risks of side effects.

By targeting the processes that take place inside the muscle cells themselves, researchers from Baker IDI Heart and Diabetes Institute, Monash University, and The University of Melbourne have identified a way to treat the frailty of cachexia in a pre-clinical model without side-effect risks.

Taking advantage of the processes by which viruses introduce genetic material into cells, the team developed purpose-built "viral vectors"; tiny particles that deliver a therapeutic gene to muscles and the heart. Once inside the muscle and heart cells, the therapeutic gene produces a protein that prevents cachexia-causing factors in the blood stream from switching on the signalling responsible for muscle wasting.

Explaining the cellular mechanism, Dr Paul Gregorevic, one of the senior members of the team, likened the muscle and heart cells to a house being battered in a storm; "By targeting how wasting signals are switched on in muscles, what we've done is try to find a way to board up the windows of the house to protect what's inside. Outside, the storm is still raging, but inside, the contents are protected."

The team demonstrated that the gene therapy approach prevented muscle wasting in pre-clinical mouse models of cachexia. As the signalling mechanisms that cause wasting in cancer have also been linked to wasting associated with other forms of chronic illness, the team suggests that this approach could also have benefits for treating frailty in other common conditions, including heart and lung disease. The team is now exploring opportunities to advance this research towards trials of the therapy in humans, and applicability of their novel gene therapy strategy for illnesses beyond cancer.
-end-


Baker IDI Heart and Diabetes Institute

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Anticancer: A New Way of Life
by David Servan-Schreiber MD PhD (Author)

The Emperor of All Maladies: A Biography of Cancer
by Siddhartha Mukherjee (Author)

The Truth about Cancer: What You Need to Know about Cancer's History, Treatment, and Prevention
by Ty M Bollinger (Author)

The Cancer-Fighting Kitchen, Second Edition: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
by Rebecca Katz (Author), Mat Edelson (Author)

The Cancer Revolution: A Groundbreaking Program to Reverse and Prevent Cancer
by Leigh Erin Connealy (Author)

F*ck Cancer: A totally inappropriate self-affirming adult coloring book (Totally Inappropriate Series) (Volume 4)
by Jen Meyers (Author)

Radical Remission: Surviving Cancer Against All Odds
by Kelly A. Turner PhD (Author)

The Metabolic Approach to Cancer: Integrating Deep Nutrition, the Ketogenic Diet, and Nontoxic Bio-Individualized Therapies
by Dr. Nasha Winters ND FABNO L.Ac Dipl.OM (Author), Jess Higgins Kelley MNT (Author), Kelly Turner (Foreword)

Cancer: 50 Essential Things to Do: 2013 Edition
by Greg Anderson (Author)

Outside the Box Cancer Therapies: Alternative Therapies That Treat and Prevent Cancer
by Dr. Mark Stengler (Author), Dr. Paul Anderson (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Why We Hate
From bullying to hate crimes, cruelty is all around us. So what makes us hate? And is it learned or innate? This hour, TED speakers explore the causes and consequences of hate — and how we can fight it. Guests include reformed white nationalist Christian Picciolini, CNN commentator Sally Kohn, podcast host Dylan Marron, and writer Anand Giridharadas.
Now Playing: Science for the People

#482 Body Builders
This week we explore how science and technology can help us walk when we've lost our legs, see when we've gone blind, explore unfriendly environments, and maybe even make our bodies better, stronger, and faster than ever before. We speak to Adam Piore, author of the book "The Body Builders: Inside the Science of the Engineered Human", about the increasingly amazing ways bioengineering is being used to reverse engineer, rebuild, and augment human beings. And we speak with Ken Thomas, spacesuit engineer and author of the book "The Journey to Moonwalking: The People That Enabled Footprints on the Moon" about...